The phase 2 trial is enrolling Fuchs dystrophy patients who are scheduled to undergo Descemet Stripping Only (DSO), also known as Descemetorhexis Without Endothelial Keratoplasty (DWEK).

Her laboratory is responsible for identification of genes for many different diseases, most recently for Age-Related Macular Degeneration (AMD) and Fuchs’ Endothelial Corneal Dystrophy (FECD). Her ...

Important insights into the mechanisms behind Fuchs endothelial corneal dystrophy (FECD), a common cause of age-related visual loss, have been revealed in a new study led by UCL researchers.